Gerresheimer

Gerresheimer, founded in 1864, is a global partner for medicine packaging, drug delivery devices, and solutions across pharma, health, well-being, and biotech. Operating in Glass & Clay, Chemicals, and Manufacturing industries, the company ensures safe and reliable medicine delivery to patients. With over a century of experience, Gerresheimer is a key player in the healthcare supply chain, offering a broad product range meeting stringent quality standards and emphasizing innovation and sustainability in its operations.

The company employs over 10,000 individuals across 26 global locations, showcasing significant operational scale and international reach. Gerresheimer's extensive product portfolio includes high-quality glass and plastic primary packaging such as bottles, vials, and jars, alongside advanced drug delivery systems like injection pens and cartridges. These offerings cater to pharmaceutical, cosmetic, and diagnostic markets, supported by robust manufacturing and quality control. To learn more about the team behind these advancements, explore Meet Gerresheimer's team.

Financially, Gerresheimer reported $2.2 billion in revenue. The company secured a $234 million debt facility in August 2025 from Helaba and BayernLB, demonstrating strong financial backing for future growth and development. This financial strength supports ongoing product development, market expansion, and technological advancement. Detailed financial performance data and projections are available at Explore financial highlights. Gerresheimer's strategic positioning and financial health enable it to continue serving critical global healthcare needs.